Swine Flu News and Research

RSS
Swine Flu or influenza A (H1N1) is a new flu virus of swine origin that first caused illness in Mexico and the United States in March and April, 2009. It’s thought that novel influenza A (H1N1) flu spreads in the same way that regular seasonal influenza viruses spread, mainly through the coughs and sneezes of people who are sick with the virus, but it may also be spread by touching infected objects and then touching your nose or mouth. Novel H1N1 infection has been reported to cause a wide range of flu-like symptoms, including fever, cough, sore throat, body aches, headache, chills and fatigue. In addition, many people also have reported nausea, vomiting and/or diarrhea.
WHO publishes comprehensive report on H1N1

WHO publishes comprehensive report on H1N1

New breakthrough: Seaweed for treatment of swine flu

New breakthrough: Seaweed for treatment of swine flu

Eight states to receive grants for local health programs

Eight states to receive grants for local health programs

New findings show seaweed extract inhibits H1N1 virus

New findings show seaweed extract inhibits H1N1 virus

Fate of the unused swine flu vaccines

Fate of the unused swine flu vaccines

BioSante Pharmaceuticals reinitiates GVAX Prostate Cancer Vaccine development

BioSante Pharmaceuticals reinitiates GVAX Prostate Cancer Vaccine development

Seasonal flu vaccine ups the risk of getting H1N1 flu

Seasonal flu vaccine ups the risk of getting H1N1 flu

Update on BioSante cancer vaccine portfolio to be presented at BIO International Convention

Update on BioSante cancer vaccine portfolio to be presented at BIO International Convention

Seasonal flu shots: Are they responsible for the adverse reactions? Investigations on

Seasonal flu shots: Are they responsible for the adverse reactions? Investigations on

Stalk structure of Mx protein restrains components of influenza virus in infected cells

Stalk structure of Mx protein restrains components of influenza virus in infected cells

BiondVax announces successful conclusion of second Phase I/II trial of Multimeric-001 Universal Flu Vaccine

BiondVax announces successful conclusion of second Phase I/II trial of Multimeric-001 Universal Flu Vaccine

Tamiflu and two other drugs used to treat influenza appear safe for pregnant women and babies: Study

Tamiflu and two other drugs used to treat influenza appear safe for pregnant women and babies: Study

Nanoviricides become registered trademark under USPTO

Nanoviricides become registered trademark under USPTO

BioSante signs Option Agreement to obtain non-exclusive worldwide license for 2A/Furin technology

BioSante signs Option Agreement to obtain non-exclusive worldwide license for 2A/Furin technology

Toddler dies after seasonal flu shot – health authorities on alert

Toddler dies after seasonal flu shot – health authorities on alert

1976 "swine flu" vaccine protects against 2009 pandemic H1N1 influenza virus

1976 "swine flu" vaccine protects against 2009 pandemic H1N1 influenza virus

Children need to be immunized against 14 vaccine-preventable diseases: Secretary of Health

Children need to be immunized against 14 vaccine-preventable diseases: Secretary of Health

April marks an important time to call attention to issues of child abuse intervention and prevention

April marks an important time to call attention to issues of child abuse intervention and prevention

News outlets examine H1N1's impact on U.S. vaccine development plans, Mexico's handling of outbreak

News outlets examine H1N1's impact on U.S. vaccine development plans, Mexico's handling of outbreak

Seasonal flu vaccine causing serious side effects in under-fives: Ban on flu vaccination program

Seasonal flu vaccine causing serious side effects in under-fives: Ban on flu vaccination program

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.